A Clinical Guide to Pleural Effusion and Ascites Analysis
Definition
A serous effusion is an abnormal accumulation of fluid within a potential space of the body, most commonly the pleural or peritoneal cavity. These spaces are normally lubricated by a minimal amount of fluid, and an effusion signifies a disruption in the delicate balance between fluid production and drainage. The foundational step in diagnosis, which dictates the entire subsequent investigative pathway, is to classify the nature of the fluid (1).
Pleural Effusion: This is an abnormal collection of fluid in the space between the lung and the chest wall. It is traditionally classified as a transudate or exudate using Light's Criteria. This distinction is clinically vital: transudates are "passive" collections resulting from systemic pressure imbalances (like heart failure or low albumin), pointing to a disease process outside the pleura. In contrast, exudates are "active" collections caused by local inflammation or disease of the pleural surface itself (like infection or cancer), which increases membrane permeability (4, 15).
Ascites: This refers to fluid accumulation in the peritoneal cavity (the abdomen). While the transudate/exudate concept can be applied, the superior and universally adopted standard for classification is the Serum-Ascites Albumin Gradient (SAAG). This simple calculation is more pathophysiologically sound because it directly reflects the presence or absence of portal hypertension, which is the driving force behind the vast majority of ascites cases. A high gradient points directly to high pressure in the portal system, making it a more accurate diagnostic tool than simply measuring total protein (8, 10).
Epidemiology
The likely causes of effusions encountered on a Malaysian ward differ significantly from those reported in Western textbooks. This is primarily due to the high local burden of specific infectious diseases, such as tuberculosis, and distinct patterns of non-communicable diseases and their risk factors among Malaysia's diverse multi-ethnic population. A clinician's diagnostic suspicion must be calibrated to this local reality.
Malaysian Context
Pleural Effusion: The diagnostic landscape is dominated by two etiologies: tuberculosis (TB) and malignancy.
A landmark Malaysian study found TB to be the definitive cause in 49% of cases, a figure far higher than in Western nations (35).
High-Yield Point: Age is a powerful stratifying factor. In Malaysian patients aged 40 and under presenting with an exudative pleural effusion, TB is the cause in an overwhelming 87% of cases. This is often a manifestation of primary TB infection rather than reactivation and should make TB the default primary differential in a young patient (35).
Malignancy is the other major contributor, accounting for about 43% of effusions. In Malaysia, the most common underlying primary cancers are lung cancer in men and breast cancer in women (35, 37).
Ascites: Local data reveals a different picture from the cirrhosis-dominant paradigm of the West. The leading causes are malignancy (28.9%) and liver cirrhosis (27.9%), with nearly equal prevalence (7).
High-Yield Point: A patient's ethnicity is a powerful predictor of the underlying cause of ascites in Malaysia, reflecting different prevalences of underlying diseases (7):
Ethnic Chinese: Malignancy (37.6%) is the leading cause, aligning with a higher incidence of certain gastrointestinal and gynecological cancers in this demographic.
Ethnic Malays: Heart Failure (20.5%) is most common, consistent with higher rates of underlying risk factors like hypertension and ischemic heart disease.
Ethnic Indians: Chronic Liver Disease (43.7%) is the predominant cause, linked to a higher prevalence of both alcoholic liver disease and MAFLD in this group.
Within the group of patients with cirrhosis, Metabolic-Associated Fatty Liver Disease (MAFLD) has emerged as the leading cause in Malaysia. This is a direct consequence of the rising national rates of obesity, type 2 diabetes, and metabolic syndrome (7, 39).
Global Context
In developed Western nations, the epidemiological picture is different. The most common causes of pleural effusion are congestive heart failure, bacterial pneumonia, and malignancy (4). For ascites, liver cirrhosis, predominantly from chronic alcohol use and Hepatitis C, is the primary cause in over 80% of cases (8).
Etiology
The extensive list of potential causes can be logically organized based on the underlying pathophysiology, which is reflected in the fluid's character.
Transudates & High-SAAG Ascites (≥ 1.1 g/dL)
These are caused by systemic pressure imbalances forcing an ultrafiltrate of plasma across healthy, intact serous membranes. The problem originates outside the cavity.
Congestive Heart Failure (Most common cause of transudative pleural effusion) (4)
Liver Cirrhosis (Most common cause of high-SAAG ascites), which can also cause a pleural effusion (hepatic hydrothorax) (4, 6)
Nephrotic Syndrome (characterised by massive protein loss via the kidneys) (4)
Constrictive Pericarditis (impaired cardiac filling mimics right heart failure) (8)
Budd-Chiari Syndrome (occlusion of the hepatic veins) (8)
Peritoneal Dialysis (iatrogenic introduction of fluid) (1)
Hypoalbuminemia from severe malnutrition or protein-losing enteropathy.
Exudates & Low-SAAG Ascites (< 1.1 g/dL)
These are caused by local disease processes that either increase the permeability of the membrane ("leaky capillaries") or obstruct lymphatic drainage. The problem is intrinsic to the cavity or adjacent organs.
Infection:
Tuberculosis: A leading cause of exudative effusions in Malaysia and other high-burden countries (35).
Bacterial Pneumonia (Parapneumonic Effusion/Empyema): A very common cause of exudative pleural effusions (4).
Malignancy:
Pleural: Metastases from lung cancer, breast cancer, or lymphoma. Primary pleural cancer (mesothelioma) is linked to asbestos exposure (37).
Peritoneal Carcinomatosis: Widespread seeding of the peritoneum from ovarian, gastric, colorectal, or pancreatic cancers (4).
Pulmonary Embolism: Causes an inflammatory reaction in the pleura, leading to an exudate in about 80% of cases (4).
Pancreatitis: Leaking pancreatic enzymes incite a potent inflammatory reaction, causing both ascites and often a left-sided pleural effusion (4).
Autoimmune Diseases: Systemic inflammation in conditions like Rheumatoid Arthritis and Systemic Lupus Erythematosus (SLE) can cause serositis, leading to exudative effusions (4).
Trauma: Can lead to Hemothorax (blood in the pleura) or Chylothorax (lymphatic fluid from a disrupted thoracic duct) (4).
Pathophysiology
The movement of fluid across serous membranes is governed by Starling's forces, a balance between hydrostatic pressure (which pushes fluid out of capillaries) and oncotic pressure (generated by proteins like albumin, which pulls fluid in) (11). An effusion occurs when this balance is tipped in favour of filtration into the space, overwhelming the lymphatic system's capacity to drain it.
Transudate Formation: This occurs when systemic forces are altered, but the capillary membrane itself remains healthy and intact.
Increased Hydrostatic Pressure: This is the classic mechanism in congestive heart failure. When the heart fails as a pump, pressure backs up into the venous system. In left heart failure, this increases pressure in the pulmonary capillaries, forcing fluid across the visceral pleura. In right heart failure, elevated systemic venous pressure increases pressure in the parietal pleural capillaries (1).
Decreased Oncotic Pressure: This is caused by severe hypoalbuminemia, most commonly from nephrotic syndrome (where albumin is lost in the urine) or cirrhosis (where the liver fails to produce albumin). With less albumin in the blood to hold fluid in, the net pressure gradient favours fluid moving out into the potential spaces (11).
Exudate Formation: This occurs due to local disease that directly damages the membrane itself, making it "leaky."
Increased Capillary Permeability: This is the hallmark of inflammation. In response to infection or malignancy, inflammatory mediators (like cytokines and Vascular Endothelial Growth Factor - VEGF) are released. These substances directly damage the capillary endothelium, creating larger pores. This allows not only fluid but also large molecules like protein and LDH, as well as inflammatory cells, to leak out into the serous space, resulting in a protein-rich, cell-rich exudate (4).
Impaired Lymphatic Drainage: The lymphatic system is the "sewerage system" for the pleural and peritoneal spaces, actively removing fluid and protein. If these drainage channels are blocked or obstructed by tumour cells infiltrating the stoma or by fibrosis from prior inflammation or radiation, fluid will inevitably accumulate, even with normal capillary pressures (1).
Clinical Presentation
Pleural Effusion
Classic Triad: The most common symptoms are dyspnea (shortness of breath), pleuritic chest pain (a sharp pain worse on inspiration), and a dry, non-productive cough (33). The severity of dyspnea depends not just on the size of the effusion but also on the patient's underlying cardiopulmonary reserve.
Diagnostic Clues on Examination: The classic signs are due to fluid insulating the chest wall from the underlying lung.
Dullness to percussion over the fluid collection (classically described as "stony dull").
Decreased or absent breath sounds on auscultation over the effusion.
Reduced tactile vocal fremitus (vibrations felt on the chest wall when the patient speaks).
Pleural Friction Rub: A coarse, grating or creaking sound heard during both inspiration and expiration. It is highly specific for pleural inflammation but is often transient, heard before a large effusion develops (when the inflamed surfaces are still in contact) or as it is resolving (50).
⚠️ Red Flag Signs & Symptoms:
Constitutional symptoms (significant weight loss, night sweats, persistent fever): Strongly suggests an underlying chronic process like TB or malignancy.
Hemoptysis (coughing up blood): A worrying sign that may indicate malignancy, pulmonary embolism, or tuberculosis.
Acute, severe dyspnea with hemodynamic instability: Raises concern for a massive pulmonary embolism or a tension phenomenon from a very large effusion.
Ascites
Common Symptoms: Progressive abdominal distension, rapid weight gain, and a non-specific feeling of fullness or bloating are the hallmarks (3, 8). As the volume increases, it can cause early satiety and shortness of breath from pressure on the diaphragm.
Diagnostic Clues on Examination: These signs require at least 1.5L of fluid to be reliably detected.
Shifting Dullness: This is the most reliable clinical sign. The examiner percusses from the midline (tympani over bowel) to the flank (dull over fluid). The patient then rolls onto their side; the area of dullness "shifts" as the fluid moves with gravity (8).
Fluid Thrill: In tense, large-volume ascites, a tap on one flank can transmit a palpable impulse ("thrill") to a hand placed on the opposite flank (8).
Stigmata of Chronic Liver Disease: A careful search for these signs is mandatory. Finding spider angiomata, palmar erythema, jaundice, gynecomastia, and caput medusae in a patient with ascites makes cirrhosis the overwhelmingly likely cause (8).
⚠️ Red Flag Signs & Symptoms:
Fever combined with abdominal pain or tenderness: These are crucial signs of Spontaneous Bacterial Peritonitis (SBP), a life-threatening infection of the ascitic fluid that requires immediate diagnosis and treatment (9).
Altered mental status (confusion, drowsiness, personality change): Suggests hepatic encephalopathy, another sign of decompensated cirrhosis.
Sister Mary Joseph Nodule: A firm, palpable nodule at the umbilicus. While rare, it is a pathognomonic sign of metastatic intra-abdominal cancer (e.g., from the stomach, colon, or ovaries) (24).
Investigations
Immediate & Bedside Tests
Thoracic/Abdominal Ultrasound: This is the best initial imaging modality. It is non-invasive, radiation-free, and more sensitive than a plain X-ray for detecting small amounts of fluid. Its most critical role is to guide needle placement for diagnostic drainage (thoracentesis/paracentesis). Real-time ultrasound guidance dramatically increases procedural success and reduces the risk of complications like pneumothorax or bowel perforation, and is now considered the standard of care (13, 27).
Diagnostic Workup
The goal is to obtain a fluid sample for analysis. A diagnostic tap is indicated for nearly all new, unexplained effusions and for any patient with known ascites who is admitted to hospital or shows signs of deterioration (13, 27).
Pleural Fluid Analysis: Light's Criteria
This is the time-tested gold standard for differentiating transudates from exudates. The fluid is classified as an exudate if it meets at least ONE of the following three criteria. If it meets none, it is a transudate (1):
Pleural Fluid Protein / Serum Protein Ratio > 0.5
Pleural Fluid LDH / Serum LDH Ratio > 0.6
Pleural Fluid LDH > 2/3 of the upper limit of normal for serum LDH
Clinical Pitfall: Light's criteria are highly sensitive (~98%) but less specific. Their main weakness is misclassifying about 25% of true transudates as exudates, particularly in patients with congestive heart failure who have been on long-term diuretic therapy. Diuresis concentrates the protein and LDH in the pleural fluid. If the clinical picture strongly suggests a transudate but the fluid is an exudate by Light's criteria, calculate the serum-pleural fluid albumin gradient. A value > 1.2 g/dL points towards a misclassified transudate (14).
Ascitic Fluid Analysis: The SAAG
The SAAG is far more accurate than total protein for determining the cause of ascites. It is a simple subtraction: SAAG = (Serum Albumin) - (Ascitic Fluid Albumin) (10).
SAAG ≥ 1.1 g/dL: Indicates the presence of portal hypertension with 97% accuracy. The high pressure in the portal system forces a low-protein ultrafiltrate into the abdomen, creating a large gradient. Common causes include cirrhosis, heart failure, and alcoholic hepatitis (8).
SAAG < 1.1 g/dL: Indicates that portal hypertension is absent. The cause is usually a disease of the peritoneum itself (e.g., inflammation or cancer) which leaks a protein-rich fluid, thus narrowing the gradient. Common causes include peritoneal carcinomatosis, tuberculous peritonitis, and pancreatitis (8).
Further Fluid Tests (Monitoring & Staging)
Cell Count & Differential:
Ascites: A polymorphonuclear (PMN) or neutrophil count ≥ 250 cells/mm³ is diagnostic for Spontaneous Bacterial Peritonitis (SBP), even if the culture is negative. This is a medical emergency and mandates immediate antibiotic therapy (21).
Pleural Fluid: The differential provides crucial clues. A lymphocytic predominance points towards a chronic process, most commonly TB or malignancy in the Malaysian context. A neutrophilic predominance suggests an acute inflammatory process like a parapneumonic effusion or pulmonary embolism (36).
Adenosine Deaminase (ADA):
This is a critical, high-yield test in Malaysia and any TB-endemic region. ADA is an enzyme released by activated T-lymphocytes in response to mycobacterial antigens.
In a patient with a lymphocytic exudate, an elevated ADA level (typically with a cutoff around 40 U/L) is highly sensitive (>90%) and specific (>90%) for a tuberculous etiology. A low ADA level has a very high negative predictive value, effectively ruling out TB (14).
Cytology: Essential if malignancy is suspected based on the clinical picture or a low-SAAG ascites. A large volume of fluid (>50 mL) should be sent to the lab to maximize the chance of detecting malignant cells (13).
Culture & Gram Stain:
High-Yield Point for SBP: For suspected SBP, it is imperative to inoculate 10-20 mL of ascitic fluid directly into aerobic and anaerobic blood culture bottles at the patient's bedside. This simple step dramatically increases the culture yield from a dismal ~50% to over 80% compared to sending the fluid to the lab in a sterile container (23).
Management
Management Principles
The absolute cornerstone of management is to treat the underlying cause. The accumulation of fluid is a symptom, not the disease itself. Interventions aimed at the fluid collection are primarily for diagnostic purposes, to relieve symptoms (palliative management), or to prevent recurrence in refractory cases (definitive management of the effusion) (47).
Acute Stabilisation (The First Hour)
This is generally only required if the effusion is causing severe respiratory distress or hemodynamic compromise (e.g., a massive tension effusion).
Airway/Breathing: Administer high-flow oxygen to maintain SpO2 >94%. If there is evidence of respiratory failure due to lung compression from a massive effusion, an urgent therapeutic drainage procedure is required to relieve the pressure (12).
Circulation: If a patient with known ascites presents with signs of SBP (fever, hypotension, abdominal pain), this is a medical emergency. Secure two large-bore IV cannulas, start empiric broad-spectrum antibiotics (e.g., IV Cefotaxime), and consider a cautious fluid bolus if hypotensive (9).
Definitive Therapy
Pleural Effusion
Therapeutic Thoracentesis: Draining 1 to 1.5 litres of fluid provides immediate and often dramatic relief from dyspnea. However, for many exudative effusions, particularly malignant ones, the fluid rapidly re-accumulates, making this a temporary palliative measure rather than a long-term solution (48).
For Recurrent Malignant Pleural Effusions (MPE): The goal is to prevent fluid re-accumulation.
Indwelling Pleural Catheter (IPC): A soft, tunneled silicone catheter is inserted into the pleural space and remains in situ long-term. This allows patients or their caregivers to drain the fluid intermittently at home using vacuum bottles. The IPC is often the preferred first-line option as it can be done as an outpatient procedure and is the treatment of choice for patients with a "trapped" (non-expandable) lung (37, 61).
Pleurodesis: This procedure aims to obliterate the pleural space. After draining the effusion, a chemical sclerosant (most commonly sterile talc) is instilled, which incites an intense inflammatory reaction that fuses the pleural layers together. A critical prerequisite for success is that the lung must be fully expandable to meet the chest wall (19).
Ascites (Cirrhosis-Related)
Sodium Restriction & Diuretics: This is the cornerstone of medical management, targeting the underlying pathophysiology of sodium and water retention.
Diet: Patients must be educated on a strict low-sodium diet, typically limited to 80-120 mmol/day (which corresponds to about 2 grams of salt) (30).
Medication: Therapy begins with an aldosterone antagonist, Spironolactone, and a loop diuretic, Furosemide, is added if needed. The combination is typically maintained at a dose ratio of 100mg spironolactone to 40mg furosemide to help maintain normal potassium levels (64).
Large Volume Paracentesis (LVP): This is the standard treatment for tense (Grade 3) or refractory ascites to provide rapid symptom relief.
Safety Critical: Rapid removal of large fluid volumes can lead to Post-Paracentesis Circulatory Dysfunction (PPCID), precipitating renal failure (hepatorenal syndrome). To prevent this, it is mandatory to co-administer intravenous albumin at a dose of 6-8 grams for every litre of ascitic fluid removed above 5 litres (41).
Transjugular Intrahepatic Portosystemic Shunt (TIPS): This is an interventional radiology procedure that creates a low-resistance channel between the portal vein and a hepatic vein, bypassing the cirrhotic liver and decompressing the portal system. It is a highly effective treatment for refractory ascites but carries a significant risk of worsening or precipitating hepatic encephalopathy (52, 66).
Liver Transplantation: For eligible patients, this is the only truly curative treatment for ascites due to end-stage liver disease, as it corrects both the portal hypertension and the synthetic dysfunction of the liver (10).
When to Escalate
A house officer must recognize these triggers and call for senior help promptly.
Call Your Senior (MO/Specialist) if:
The patient shows any clinical signs of Spontaneous Bacterial Peritonitis (fever, abdominal pain, confusion). Treatment must not be delayed.
The patient develops acute respiratory distress, hypotension, or signs of re-expansion pulmonary edema during or after a drainage procedure.
There is a suspicion of empyema (pus in the pleural space), which requires urgent chest tube drainage.
The patient has refractory ascites (ascites that is unresponsive to high-dose diuretics or recurs rapidly after LVP), as they may need evaluation for TIPS or transplant.
The patient develops significant renal impairment (e.g., creatinine rise >50%) or severe electrolyte abnormalities (e.g., hyponatremia <125 mmol/L, severe hyperkalemia) as a complication of diuretic therapy.
References
Pleural Effusion - StatPearls - NCBI Bookshelf. (n.d.). Retrieved July 23, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK448189/
Ascites - Symptoms, Causes, Complications, Prevention, Treatment - PACE Hospitals. (n.d.). Retrieved July 23, 2025, from https://www.pacehospital.com/ascites-symptoms-causes-complications-prevention-and-treatment
Ascites: What it is, Symptoms, Causes & Treatment - Cleveland Clinic. (n.d.). Retrieved July 23, 2025, from https://my.clevelandclinic.org/health/diseases/14792-ascites
Pleural effusion - Wikipedia. (n.d.). Retrieved July 23, 2025, from https://en.wikipedia.org/wiki/Pleural_effusion
Pleural Effusions | DYSK - JustInTimeMedicine. (n.d.). Retrieved July 23, 2025, from https://www.justintimemedicine.com/curriculum/dysk-pleural-effusions
Moore, K. P., & Aithal, G. P. (2006). Cirrhotic ascites review: Pathophysiology, diagnosis and management. Alimentary pharmacology & therapeutics, 24(8), 1191-1206. https://pmc.ncbi.nlm.nih.gov/articles/PMC3664283/
Goh, K. L., et al. (2024). The Epidemiology of Ascites in a Multi-Ethnic Asian Population. Journal of Clinical and Experimental Hepatology. https://pmc.ncbi.nlm.nih.gov/articles/PMC11825974/
Ascites - Wikipedia. (n.d.). Retrieved July 23, 2025, from https://en.wikipedia.org/wiki/Ascites
Ascites | Causes, Symptoms, Treatment and Support - Guts UK. (n.d.). Retrieved July 23, 2025, from https://gutscharity.org.uk/advice-and-information/conditions/ascites/
Ascites - StatPearls - NCBI Bookshelf. (n.d.). Retrieved July 23, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK470482/
Zocchi, L. (2024). Clinical overview of the physiology and pathophysiology of pleural fluid formation and reabsorption. ERJ Open Research, 10(5), 00050-2024. https://publications.ersnet.org/content/erjor/10/5/00050-2024
Pleural Effusion - Lung and Airway Disorders - Merck Manual Consumer Version. (n.d.). Retrieved July 23, 2025, from https://www.merckmanuals.com/home/lung-and-airway-disorders/pleural-and-mediastinal-disorders/pleural-effusion
Porcel, J. M., et al. (2014). Recommendations of Diagnosis and Treatment of Pleural Effusion. Archivos de Bronconeumología (English Edition), 50(6), 235-249. https://www.archbronconeumol.org/en-recommendations-diagnosis-treatment-pleural-effusion--articulo-S1579212914001293
He, L., & Chen, Y. (2019). Diagnostic approach to pleural effusions. AME Medical Journal. https://amj.amegroups.org/article/view/4753/html
Transudate vs exudate (video) | Khan Academy. (n.d.). Retrieved July 23, 2025, from https://www.khanacademy.org/science/health-and-medicine/respiratory-system-diseases/pleural-effusion-2/v/transudate-vs-exudate
PE (Pleural Effusion) - St Vincent's Lung Health. (n.d.). Retrieved July 23, 2025, from https://www.svhlunghealth.com.au/conditions/pleural-effusion
Ascitic Fluid - LITFL. (n.d.). Retrieved July 23, 2025, from https://litfl.com/ascitic-fluid/
Diagnosis and Management of Ascites - Core Concepts - Hepatitis C Online. (n.d.). Retrieved July 23, 2025, from https://www.hepatitisc.uw.edu/pdf/management-cirrhosis-related-complications/ascites-diagnosis-management/core-concept/all
Ascites (Nursing) - StatPearls - NCBI Bookshelf. (n.d.). Retrieved July 23, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK568749/
The diagnostic work-up in patients with ascites: current ... - NJM. (n.d.). Retrieved July 23, 2025, from https://www.njmonline.nl/getpdf.php?id=1761
European Association for the Study of the Liver. (2018). EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of hepatology, 69(2), 406-460. https://easl.eu/wp-content/uploads/2018/10/Hepatorenal-Cirrhosis-English-report.pdf
Jany, B., & Welte, T. (2019). Pleural Effusion in Adults—Etiology, Diagnosis, and Treatment. Deutsches Ärzteblatt International, 116(21), 377-386. https://pmc.ncbi.nlm.nih.gov/articles/PMC6647819/
Liam, C. K., & Lim, K. H. (1995). Pleural Effusion in 100 Malaysian Patients. The Medical journal of Malaysia, 50(1), 48-53. https://pubmed.ncbi.nlm.nih.gov/1840436/
Zhai, K., et al. (2016). Tuberculous pleural effusion. Journal of Thoracic Disease, 8(7), E486-E494. https://jtd.amegroups.org/article/view/7851/html
Ministry of Health Malaysia. (n.d.). Indwelling pleural catheter (IPC). Retrieved July 23, 2025, from https://www.moh.gov.my/index.php/database_stores/attach_download/347/325
Bernama. (2023). Liver Diseases Still Prevalent Among Malaysians. Retrieved July 23, 2025, from https://bernama.com/en/news.php?id=2290107
Asia–Pacific association for study of liver guidelines on ... (n.d.). Retrieved July 23, 2025, from https://nottingham-repository.worktribe.com/output/25670695
Karkhanis, V. S., & Joshi, J. M. (2012). Pleural effusion: diagnosis, treatment, and management. Open access emergency medicine: OAEM, 4, 31–52. https://pmc.ncbi.nlm.nih.gov/articles/PMC4753987/
Pleural Effusion | UCSF Health. (n.d.). Retrieved July 23, 2025, from https://www.ucsfhealth.org/conditions/pleural-effusion
Kalantri, S., et al. (2008). Accuracy of the physical examination in evaluating pleural effusion. Cleveland Clinic journal of medicine, 75(4), 297-303. https://www.ccjm.org/content/ccjom/75/4/297.full.pdf
Ascites | Johns Hopkins Medicine. (n.d.). Retrieved July 23, 2025, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/ascites
Feller-Kopman, D., & Reddy, C. (2018). Malignant Pleural Effusion Guidelines. American Association for Bronchology and Interventional Pulmonology. https://www.aabronchology.org/malignant-pleural-effusion-guidelines
British Society of Gastroenterology. (2006). Guidelines on the management of ascites in cirrhosis. Gut, 55(Suppl 6), vi1-vi12. https://pmc.ncbi.nlm.nih.gov/articles/PMC1860002/
Runyon, B. A. (2021). Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome. Cleveland Clinic Journal of Medicine, 90(4), 209-221. https://www.ccjm.org/content/90/4/209
